Clinical Trial Update: Efficacy and Safety Study of TUDCA Compare UDCA to Treatment Chronic Cholestatic Liver Disease-PBC [Phase 3]

View source ↗

Summary

Phase 3 efficacy and safety trial comparing tauroursodeoxycholic acid (TUDCA) with ursodeoxycholic acid (UDCA) for primary biliary cholangitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Tauroursodeoxycholic Acid (TUDCA) (tauroursodeoxycholic acid)
• Ursodeoxycholic acid (UDCA) (ursodeoxycholic acid)

Snippet

Sponsor: Beijing Trendful Kangjian Medical Information Consulting Limited Company | Conditions: Cholestatic Liver Disease | Phase 3 | Status: COMPLETED